GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors

By sjmartinez • September 1, 2024

Patel R, Wadid M, Makwana B, Kumar A, Khadke S, Bhatti A, Banker A, Husami Z, Labib S, Venesy D, Fonarow G, Kosiborod M, Al-Kindi S, Bhatt DL, Dani S, Nohria A, Butler J, Ganatra S. GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors. JACC Heart Fail. 2024 Aug 16:S2213-1779(24)00561-4. doi: 10.1016/j.jchf.2024.07.006. Epub ahead of print. PMID: 39207323.

Tags: Cardiology/Epi, GLP-1 receptor agonists, Heart failure with preserved ejection fraction, Obesity, overweight, Publications, SGLT2is

Standardized Data Elements for Patients With Acute Pulmonary Embolism: A Consensus Report from the Pulmonary Embolism Research Collaborative

Rosenfield K, Bowers TR, Barnett CF, Davis GA, Giri J, Horowitz JM, Huisman MV, Hunt BJ, Keeling B, Kline JA, Klok FA, Konstantinides SV, Lanno[...]

Observance of rare congenital anomaly: dual right coronary artery

Bishay R, Aldana-Bitar J, Budoff MJ. Observance of rare congenital anomaly: dual right coronary artery. Coron Artery Dis. 2024 Sep 12. doi: 10.1097/MCA.0000000000001423. Epub ahead[...]

Four-dimensional endocardial surface imaging with dynamic virtual reality rendering: a technical note

Yoo SJ, Valverde I, Perens GS, Nguyen KL, Finn JP. Four-dimensional endocardial surface imaging with dynamic virtual reality rendering: a technical note. Transl Pediatr. 2024[...]